Harvard Apparatus Regenerative Technology, Inc. (HRGN) › Operating IncomeHarvard Apparatus Regenerative Technology, Inc. (HRGN) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2012: -$6.71M2013: -$8.82M2014: -$11.06M2015: -$11.70M2016: -$12.13M2017: -$11.47M2018: -$7.84M2019: -$8.87M2020: -$5.33M2021: -$8.64M2022: -$6.15M2023: -$8.99M2024: -$7.73M2025: -$6.92M-$6.92M2012Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$6.92M+10.5%2024-$7.73M+14.1%2023-$8.99M-46.1%2022-$6.15M+28.8%2021-$8.64M-62.2%2020-$5.33M+40.0%2019-$8.87M-13.1%2018-$7.84M+31.6%2017-$11.47M+5.4%2016-$12.13M-3.6%2015-$11.70M-5.8%2014-$11.06M-25.4%2013-$8.82M-31.3%2012-$6.71M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share